Impact of 24-hour Subcutaneous Levodopa/Carbidopa Infusion (ND0612) on Motor Function: Efficacy Outcomes from the Phase 3 BouNDless Study (S37.001)

To evaluate the effect of investigational ND0612 on PD motor state characteristics in patients with PD experiencing motor fluctuations from the BouNDless (NCT04006210) study.